HADEA/2022/OP/0024 – Empfehlungen und Leitlinien für die Behandlung von Substanzen menschlichen Ursprungs in Krankenhäusern

Information

02 - Contract notice
Offenes Verfahren
23.01.2023 09:21 (GMT+01:00)
01.03.2023 15:00 (GMT+01:00)

Buyer

European Health and Digital Executive Agency (HaDEA), HADEA.A.2.001 – EU4Health III European Health and Digital Executive Agency (HaDEA), HADEA.A.2.001 – EU4Health III
Place Charles Rogier 16, COV2
1210 Brussels
BELGIUM

Closing date has passed.

Short description

Empfehlungen und Leitlinien für die Behandlung von Substanzen menschlichen Ursprungs in Krankenhäusern.

Files (click "Show interest" to get access)

Name Size
HADEA-149_EN.zip 2,38 MB

Mercell Germany

Part of the Mercell Group, one of Europe’s leading providers of e tender systems and information between buyers and suppliers in the professional market.

Our producs

Tender offer
ESPD
Tender consulting
E tender system

About us

The company
Departments
Ethical guidelines
Investor information
Career

Contact us

Write to us

+47 21 01 88 60
Mercell Germany | Askekroken 11, 0277 OSLO, Norwegen
Cookie info |Contact us | Einloggen